| |
| |
|
| Insider
Information: |
Czirr James C |
| Relationship: |
10% Owner |
| City: |
Sandpoint |
| State: |
ID |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
6,168,940 |
|
|
Indirect Shares
|
5,922,207 |
|
|
| Direct
Value |
$20,604,260 |
|
|
|
Indirect Value
|
$19,780,171 |
|
|
| Total
Shares |
12,091,147 |
|
|
| Total
Value |
$40,384,431 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -39.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
10% Owner |
2022-07-22 |
6,168,940 |
2024-04-23 |
5,922,207 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2024-04-23 |
4 |
S |
$3.06 |
$11,252 |
I/I |
(3,677) |
5,922,207 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
10% Owner |
– – • |
2024-04-22 |
4 |
S |
$3.06 |
$65,248 |
I/I |
(21,323) |
5,925,884 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2022-07-22 |
4 |
AS |
$2.09 |
$20,870 |
D/D |
(10,000) |
6,168,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2022-02-02 |
4 |
AS |
$2.10 |
$21,000 |
D/D |
(10,000) |
6,178,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2022-01-11 |
4 |
AS |
$2.10 |
$21,000 |
D/D |
(10,000) |
6,188,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-12-02 |
4 |
AS |
$2.37 |
$23,700 |
D/D |
(10,000) |
6,198,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-11-01 |
4 |
AS |
$3.19 |
$31,900 |
D/D |
(10,000) |
6,208,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-10-15 |
4 |
S |
$3.37 |
$33,700 |
D/D |
(10,000) |
6,218,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-10-04 |
4 |
AS |
$3.62 |
$36,200 |
D/D |
(10,000) |
6,228,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-09-01 |
4 |
AS |
$3.91 |
$39,100 |
D/D |
(10,000) |
6,238,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-06-01 |
4 |
AS |
$3.91 |
$39,100 |
D/D |
(10,000) |
6,268,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-05-03 |
4/A |
AS |
$3.84 |
$38,400 |
D/D |
(10,000) |
6,278,940 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-05-03 |
4 |
AS |
$3.84 |
$38,400 |
D/D |
(10,000) |
6,288,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-04-28 |
4/A |
AS |
$5.02 |
$50,200 |
D/D |
(10,000) |
6,288,940 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-04-26 |
4 |
AS |
$4.47 |
$33,525 |
D/D |
(7,500) |
6,298,940 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-04-23 |
4 |
AS |
$3.95 |
$19,750 |
D/D |
(5,000) |
6,306,440 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-04-22 |
4 |
AS |
$3.52 |
$17,600 |
D/D |
(5,000) |
6,311,440 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-03-01 |
4 |
AS |
$2.31 |
$23,100 |
D/D |
(10,000) |
6,326,440 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-02-02 |
4 |
AS |
$2.04 |
$20,400 |
D/D |
(10,000) |
6,336,440 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • • |
2021-01-04 |
4 |
AS |
$2.23 |
$22,300 |
D/D |
(10,000) |
6,346,440 |
0 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Managing Member of GP |
– – – |
2019-10-10 |
4 |
S |
$3.73 |
$63,325 |
D/D |
(17,000) |
6,385,790 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Managing Member of GP |
– – – |
2019-08-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(38,690) |
6,402,790 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Managing Member of GP |
– – – |
2019-07-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(306) |
6,441,480 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Managing Member of GP |
– – – |
2019-05-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(67,515) |
6,441,786 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Managing Member of GP |
– – – |
2019-01-11 |
4 |
OE |
$1.12 |
$8,508,089 |
D/D |
3,789,346 |
6,509,301 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
